// App-Quantinova.ai

: LONGITUDINAL THERAPEUTIC DRUG MONITORING TO OPTIMIZE PEGASPARGASE DOSING IN ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

Researchers

Presenter

  • Maria Moreno

Principal Investigators

  • Amanda Wolfe

  • Celina Dara

  • Karen Yee

  • Andre Schuh

Medical Centers

  • Department of Pharmacy,Princess Margaret Cancer Centre, University Health Network,Toronto,Canada;Leslie Dan Faculty of Pharmacy,University of Toronto,Toronto,Canada

  • Elizabeth Bruyere Hosp, Ottawa, ON, Canada

  • Medical Oncology and Hematology,Princess Margaret Cancer Centre, University Health Network,Toronto,Canada;Department of Medicine,University of Toronto,Toronto,Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Pegaspargase

  • Oncaspar

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved